Ultomiris 300 mg/30 mL concentrate for solution for infusion
ALXN1210-TMA-314
Phase 3 small_molecule active
Quick answer
Ultomiris 300 mg/30 mL concentrate for solution for infusion for Hematopoietic stem cell transplant-associated thrombotic microangiopathy(HSCT- TMA) is a Phase 3 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Hematopoietic stem cell transplant-associated thrombotic microangiopathy(HSCT- TMA)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active